Import Betulinic Acid — Buy in wholesale FOB from Supplier in China

Zhenyibio Technology Inc. supplies Betulinic Acid (CAS 472-15-1, EINECS 207-448-8) as a white powder with stated purity of 98% and molecular composition C30H48O3. The material derives from extraction of birch bark, specifically targeting the triterpene content of Betula species, with the supplier emphasising its anti-inflammatory, antioxidant, and antitumor properties in cosmetic and pharmaceutical applications. The 98% purity grade positions this material at the higher end of commercial offerings, suitable for formulation in premium skincare serums, creams, and research-grade pharmaceutical preparations where defined impurity profiles are required.

The triterpenoid structure of Betulinic Acid confers selective cytotoxicity against malignant cells while sparing normal cells, a mechanism attributed to mitochondrial membrane perturbation and downstream caspase activation rather than DNA intercalation. In cosmetic contexts, the compound's anti-inflammatory activity addresses erythema and irritation pathways, making it relevant for sensitive skin formulations and conditions such as eczema and psoriasis. Zhenyibio Technology Inc. packages this material in 1kg aluminium foil bags or 25kg fibre drums, standard formats that provide moisture and light protection during storage and international transit. Buyers should confirm with the supplier whether the 98% purity refers to HPLC area percentage or mass balance, as analytical methodology affects comparability across suppliers.

Demand for this material concentrates in the clean beauty and natural skincare sectors, where botanical provenance and absence of synthetic analogues support marketing claims. Pharmaceutical researchers utilise Betulinic Acid in oncology programme pipelines, though buyers should distinguish between research chemical and GMP-grade specifications when discussing applications with Zhenyibio Technology Inc. The supplier's location in Xi'an, Shaanxi Province, places it within a recognised Chinese hub for botanical extraction and traditional medicine-derived active ingredients, though proximity to other suppliers does not imply equivalent quality systems. Trade discussions should cover regulatory support documentation for destination markets, including safety assessments, REACH registration status if exporting to Europe, and any existing cosmetic ingredient dossiers.

Zhenyibio Technology Inc. is headquartered at No.29 Kejiliulu, Gaoxin District, Xi'an City, Shaanxi Province, China 710000, locating it in the Xi'an Hi-Tech Industries Development Zone, a district with concentration of biotechnology and pharmaceutical enterprises. The supplier holds a harbor trust tier with no stated additional verification, and like the parallel listing, shows a 0.00% response rate with zero recorded response hours, indicating potential challenges in pre-sales communication that buyers should anticipate. No establishment date, employee count, annual revenue, or manufacturing facility certifications are disclosed in the profile, so assessment of production scale and quality management maturity requires direct inquiry and potential on-site or third-party audit.

The supplier's product description emphasises antitumor, antiviral, and anti-inflammatory applications, with specific mention of apoptosis induction and selective cancer cell killing, claims that fall into regulated therapeutic territory in many jurisdictions. Buyers should verify whether Zhenyibio Technology Inc. positions this material as a cosmetic ingredient, a research chemical, or an active pharmaceutical ingredient, as regulatory pathways and documentation requirements differ substantially. The profile does not state GMP certification, ISO 9001 registration, or FDA facility registration, so pharmaceutical buyers must conduct supplier qualification including quality agreement negotiation and audit if the material is intended for clinical or commercial drug product manufacture.